Annual Working Capital
$181.75 M
-$114.45 M-38.64%
31 December 2023
Summary:
Foghorn Therapeutics annual working capital is currently $181.75 million, with the most recent change of -$114.45 million (-38.64%) on 31 December 2023. During the last 3 years, it has risen by +$9.90 million (+5.76%). FHTX annual working capital is now -55.77% below its all-time high of $410.87 million, reached on 31 December 2021.FHTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$214.41 M
-$24.34 M-10.19%
30 September 2024
Summary:
Foghorn Therapeutics quarterly working capital is currently $214.41 million, with the most recent change of -$24.34 million (-10.19%) on 30 September 2024. Over the past year, it has increased by +$980.00 thousand (+0.46%). FHTX quarterly working capital is now -47.82% below its all-time high of $410.87 million, reached on 31 December 2021.FHTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.6% | +0.5% |
| 3 y3 years | +5.8% | +104.9% |
| 5 y5 years | +392.0% | - |
FHTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.8% | +5.8% | -47.8% | +104.9% |
| 5 y | 5 years | -55.8% | +4193.5% | -47.8% | +4965.2% |
| alltime | all time | -55.8% | +4193.5% | -47.8% | +4965.2% |
Foghorn Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $214.41 M(-10.2%) |
| June 2024 | - | $238.75 M(+49.7%) |
| Mar 2024 | - | $159.46 M(-12.3%) |
| Dec 2023 | $181.75 M(-38.6%) | $181.75 M(-14.8%) |
| Sept 2023 | - | $213.43 M(-8.7%) |
| June 2023 | - | $233.85 M(-11.7%) |
| Mar 2023 | - | $264.90 M(-10.6%) |
| Dec 2022 | $296.19 M | $296.19 M(-8.2%) |
| Sept 2022 | - | $322.55 M(-8.4%) |
| June 2022 | - | $352.10 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $381.58 M(-7.1%) |
| Dec 2021 | $410.87 M(+139.1%) | $410.87 M(+292.6%) |
| Sept 2021 | - | $104.66 M(-18.4%) |
| June 2021 | - | $128.26 M(-13.9%) |
| Mar 2021 | - | $148.98 M(-13.3%) |
| Dec 2020 | $171.84 M(+3959.6%) | $171.84 M(+204.3%) |
| Sept 2020 | - | $56.46 M(+144.4%) |
| June 2020 | - | $23.10 M(+445.8%) |
| Dec 2019 | $4.23 M(-88.5%) | $4.23 M |
| Dec 2018 | $36.94 M | - |
FAQ
- What is Foghorn Therapeutics annual working capital?
- What is the all time high annual working capital for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual working capital year-on-year change?
- What is Foghorn Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly working capital year-on-year change?
What is Foghorn Therapeutics annual working capital?
The current annual working capital of FHTX is $181.75 M
What is the all time high annual working capital for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual working capital is $410.87 M
What is Foghorn Therapeutics annual working capital year-on-year change?
Over the past year, FHTX annual working capital has changed by -$114.45 M (-38.64%)
What is Foghorn Therapeutics quarterly working capital?
The current quarterly working capital of FHTX is $214.41 M
What is the all time high quarterly working capital for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly working capital is $410.87 M
What is Foghorn Therapeutics quarterly working capital year-on-year change?
Over the past year, FHTX quarterly working capital has changed by +$980.00 K (+0.46%)